Unknown PHASE4 INTERVENTIONAL 2-arm NCT02475642

Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation (POWDER-AF)

Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment in Subjects With Recurrent Atrial Fibrillation: A Prospective 2-Centre Randomized Controlled Clinical Study (POWDER-AF)

Sponsor: AZ Sint-Jan AV

Conditions Atrial Fibrillation

Interventions PVI+ADT PVI-ADT

Updated 7 times since 2017 Last updated: Apr 26, 2016 Started: Mar 31, 2014 Primary completion: Aug 31, 2016 Completion: Aug 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Atrial Fibrillation and is currently ongoing. AZ Sint-Jan AV leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

May 2018 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Active Not Recruiting → Unknown Status
Jan 2017 — May 2018 [monthly]

Active Not Recruiting PHASE4

First recorded

Mar 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AZ Sint-Jan AV
VZW Cardiovascular Research Center Aalst

Data source: VZW Cardiovascular Research Center Aalst

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Aalst, Belgium
• Bruges, Belgium